GALT PHARMACEUTICALS Trademark

Trademark Overview


On Wednesday, June 14, 2017, a trademark application was filed for GALT PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the GALT PHARMACEUTICALS trademark a serial number of 87488370. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 1, 2019. This trademark is owned by Galt Pharmaceuticals, LLC. The GALT PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical research and development services, including but not limited to, development and evaluation of products for the treatment of Meniere's disease, and development of pharmaceutical preparations and medicines derived from underused, undeveloped, discontinued, and/or previously marketed compounds

Pharmaceutical clinical services, namely, development of new treatment modalities in the nature of pharmaceutical treatment protocols derived from underused, undeveloped, discontinued and/or previously marketed compounds in unmet patient health needs
galt pharmaceuticals

General Information


Serial Number87488370
Word MarkGALT PHARMACEUTICALS
Filing DateWednesday, June 14, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 1, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPharmaceutical research and development services, including but not limited to, development and evaluation of products for the treatment of Meniere's disease, and development of pharmaceutical preparations and medicines derived from underused, undeveloped, discontinued, and/or previously marketed compounds
Goods and ServicesPharmaceutical clinical services, namely, development of new treatment modalities in the nature of pharmaceutical treatment protocols derived from underused, undeveloped, discontinued and/or previously marketed compounds in unmet patient health needs
Name/Portrait Description and/or Consent StatementThe name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 20, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 20, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGalt Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30339

Trademark Events


Event DateEvent Description
Wednesday, May 1, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, May 1, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, October 3, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 3, 2018NON-FINAL ACTION E-MAILED
Wednesday, October 3, 2018NON-FINAL ACTION WRITTEN
Wednesday, September 12, 2018DIVISIONAL PROCESSING COMPLETE
Thursday, September 6, 2018DIVISIONAL REQUEST RECEIVED
Tuesday, September 11, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 6, 2018TEAS REQUEST TO DIVIDE RECEIVED
Thursday, September 6, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 14, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, March 16, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, March 16, 2018FINAL REFUSAL E-MAILED
Friday, March 16, 2018FINAL REFUSAL WRITTEN
Tuesday, February 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 14, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 27, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 23, 2018ASSIGNED TO LIE
Wednesday, February 14, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, February 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 15, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 15, 2017NON-FINAL ACTION E-MAILED
Friday, September 15, 2017NON-FINAL ACTION WRITTEN
Thursday, September 14, 2017ASSIGNED TO EXAMINER
Tuesday, June 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 17, 2017NEW APPLICATION ENTERED IN TRAM